Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.
J Nanobiotechnology
; 19(1): 150, 2021 May 21.
Article
in En
| MEDLINE
| ID: mdl-34020670
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Wound Healing
/
Diabetes Mellitus
/
Exosomes
/
Mesenchymal Stem Cells
/
Pioglitazone
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Nanobiotechnology
Year:
2021
Type:
Article
Affiliation country:
China